Literature DB >> 22336282

[Association between inhalable particulate matter and mortality in China: a meta-analysis].

Wen Huang1, Hong-yuan Wang, Qi Wang.   

Abstract

OBJECTIVE: Synthesize the relevant research and then discuss the influence of inhalable particulate matter (PM(10)) on mortality by exposure-response analysis.
METHODS: The eligible research papers which studied the association between PM(10) and overall mortality of residents, the mortality of cardiovascular and cerebrovascular diseases and the mortality of respiratory diseases; and 21 pieces of the papers were adopted in this study. The papers were analyzed by Stata 9.0 software, and the exposure-response coefficient of PM(10) and mortality were extracted. The effect size was amalgamated by fixed or random effects, and the sensitivity analysis and publication bias of the results were detected and adjusted.
RESULTS: Each 10 µg/m(3) increase of PM(10) was associated with estimated relative risk (RR) of daily all-course mortality, the mortality of cardiovascular and cerebrovascular diseases and the mortality of respiratory diseases at 1.0033 (95%CI: 1.0022 - 1.0044), 1.0045 (95%CI: 1.0029 - 1.0062) and 1.0056 (95%CI: 1.0033 - 1.0079), respectively. After the publication bias was adjusted, the RR of daily all-cause, cardiovascular and cerebrovascular diseases and respiratory diseases mortality was reduced to 1.0012 (95%CI: 1.0002 - 1.0022), 1.0011 (95%CI: 0.9996 - 1.0026) and 1.0023 (95%CI: 1.0001 - 1.0045).
CONCLUSION: The increase of the concentration of PM(10) led to the increase of the daily all-course mortality, the mortality of cardiovascular and cerebrovascular diseases and the mortality of respiratory diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22336282

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  1 in total

1.  Meta-analysis of adverse health effects due to air pollution in Chinese populations.

Authors:  Hak-Kan Lai; Hilda Tsang; Chit-Ming Wong
Journal:  BMC Public Health       Date:  2013-04-18       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.